iMetabolic Biopharma Corporation (iMBP Corp) is an exciting early stage pre-clinical biopharma company that is developing First In Class therapeutics for the treatment of rare, metabolic and cardiometabolic diseases. Based upon its iPlatform approach, iMBP Corp is addressing the needs of a spectrum of disorders with overlapping pathology.
Based in Tempe, AZ; iMBP Corp is growing its operations to support the development of its therapeutic pipeline. As there is significant unmet need in the development of drugs in this space, the iMBP Corp team and its network of physicians and researchers are poised to move forward ground breaking science to help improve patient care.
"Restoring Health Through Innovation"